No not at all
QUAGEN is mentioned in the first of the announce
Ellume’s partnerships with GSK and QIAGEN validates successful global Point of Care (POC) strategy•Ellume and Anteo collaboration confirms performance enhancing capabilities of AnteoBind for POC
(from announcement)
So obviously anteobind will be used. .Why not expect some payment.
validation of anteobind with ellume partnership, page-10
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
